Approval · Notice of Compliance 4049 · 1997
RISPERDAL: Notice of Compliance 4049
Issued January 8, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4049
- Date
- January 8, 1997
- Company
- Janssen PharmaceuticaBeerse, Saone Et Loire, Belgium
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Antipsychotic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RISPERDAL | 02230455 | Cancelled Post Market |
Medicinal ingredients
- RISPERIDONE 5 MG per TAB